Mechanisms underlying the vasorelaxation of human internal mammary artery induced by (-)-epicatechinEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72015-09-0128PREAI
Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathyPHARMACOLOGICAL RESEARCHIF10.52015-07-0122PREAI
EPICATECHIN INDUCED VASORELAXATION OF HUMAN INTERNAL MAMMARY ARTERYATHEROSCLEROSISIF5.72015-07-012PREAI
Nicorandil directly and cyclic GMP-dependently opens K+ channels in human bypass graftsJOURNAL OF PHARMACOLOGICAL SCIENCESIF2.92015-06-0113OAAI
Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesiaPHARMACOLOGY BIOCHEMISTRY AND BEHAVIORIF2.52011-01-0116PREAI
Analysis of interaction between oxcarbazepine and COX-inhibitors in a rat model of inflammatory hyperalgesiaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic miceEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72010-02-0124PREAI
RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activityEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72008-08-010PREAI
Synergistic interaction between gabapentin and oxcarbazepine in a mouse model of painful diabetic neuropathyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72007-10-010PREAI
Are GABAA receptors containing α5 Subunits contributing to the sedative properties of benzodiazepine site agonists?NEUROPSYCHOPHARMACOLOGYIF7.12007-03-2876OAAI
The effects of α2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory painPAINIF5.52006-11-0125PRE
Benzodiazepine site inverse agonists and locomotor activity in rats: Bimodal and biphasic influencePHARMACOLOGY BIOCHEMISTRY AND BEHAVIORIF2.52006-05-0110PREAI
Peripheral antinociception by carbamazepine in an inflammatory mechanical hyperalgesia model in the rat: a new target for carbamazepine?JOURNAL OF PHARMACOLOGICAL SCIENCESIF2.92006-01-0119OAAI
Involvement of α2-adrenoceptors in the local peripheral anti-hyperalgesic effect of carbamazepineEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72006-01-010PREAI
Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention:: differential antagonism by flumazenil and β-CCtPSYCHOPHARMACOLOGYIF3.32005-02-1822PREAI
Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze:: differential antagonism by flumazenil and β-CCtPHARMACOLOGY BIOCHEMISTRY AND BEHAVIORIF2.52004-10-0145PREAI
The antinociceptive effect of oxcarbazepine in a rat model of inflammatory hyperalgesiaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72004-10-010PREAI
The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonistsPAINIF5.52004-10-0138PRE
The involvement of adenosine A1 receptors in the antinociceptive effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesiaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72004-10-010PREAI